{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T08:16:36Z","timestamp":1773648996883,"version":"3.50.1"},"reference-count":10,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Pract Neurol"],"accepted":{"date-parts":[[2025,9,2]]},"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1136\/pn-2025-004804","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:35:26Z","timestamp":1757914526000},"page":"104-105","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Biosimilar rollouts: practice, pitfalls and the importance of effective communication"],"prefix":"10.1136","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2993-585X","authenticated-orcid":false,"given":"Ruth","family":"Dobson","sequence":"first","affiliation":[{"name":"Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK"},{"name":"Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Dorsey","sequence":"additional","affiliation":[{"name":"Department of Neurology, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Varley","sequence":"additional","affiliation":[{"name":"Department of Neurology, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Paling","sequence":"additional","affiliation":[{"name":"Department of Neurology, Royal Hallamshire Hosptial, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joela","family":"Mathews","sequence":"additional","affiliation":[{"name":"Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5024-3615","authenticated-orcid":false,"given":"Tarunya","family":"Arun","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK"},{"name":"University of Warwick, Warwick, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4738-0760","authenticated-orcid":false,"given":"Alasdair J","family":"Coles","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,9,14]]},"reference":[{"key":"2026031600451054000_26.2.104.1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s40259-024-00671-4","article-title":"Introducing the Biosimilar Paradigm to Neurology: The Totality of Evidence for the First Biosimilar Natalizumab","volume":"38","author":"Selmaj","year":"2024","journal-title":"BioDrugs"},{"key":"2026031600451054000_26.2.104.2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40259-021-00493-8","article-title":"Is There Any Research Evidence Beyond Surveys and Opinion Polls on Automatic Substitution of Biological Medicines? A Systematic Review","volume":"35","author":"Tolonen","year":"2021","journal-title":"BioDrugs"},{"key":"2026031600451054000_26.2.104.3","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-015-0415-3","article-title":"What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs","volume":"13","author":"Dunne","year":"2015","journal-title":"BMC Med"},{"key":"2026031600451054000_26.2.104.4","first-page":"952","article-title":"The Biosimilar Nocebo Effect? A Systematic Review of Double-Blinded Versus Open-Label Studies","volume":"24","author":"Odinet","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"key":"2026031600451054000_26.2.104.5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1177\/13524585251346652","article-title":"A comparison of JC virus assay performance provided with originator and biosimilar natalizumab","volume":"31","author":"Varley","year":"2025","journal-title":"Mult Scler"},{"key":"2026031600451054000_26.2.104.6","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/13524585251322683","article-title":"Beyond the switch to the biosimilar of natalizumab: What is the impact of changing the JCV test?","volume":"31","author":"Vukusic","year":"2025","journal-title":"Mult Scler"},{"key":"2026031600451054000_26.2.104.7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamaneurol.2025.0337","article-title":"Accuracy of New John Cunningham Virus Antibody Assay in Natalizumab-Treated Patients With Multiple Sclerosis","volume":"82","author":"Gelissen","year":"2025","journal-title":"JAMA Neurol"},{"key":"2026031600451054000_26.2.104.8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/13524585251346658","article-title":"Diagnostic uncertainty in the era of biosimilar natalizumab\u2014The case for harmonizing anti-JCV antibody testing","volume":"31","author":"Ziemssen","year":"2025","journal-title":"Mult Scler"},{"key":"2026031600451054000_26.2.104.9","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1177\/13524585221116269","article-title":"Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations","volume":"28","author":"Brownlee","year":"2022","journal-title":"Mult Scler"},{"key":"2026031600451054000_26.2.104.10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41584-023-01048-7","article-title":"Maximizing the success of biosimilar implementation","volume":"19","author":"Alten","year":"2023","journal-title":"Nat Rev Rheumatol"}],"container-title":["Practical Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/pn-2025-004804","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T07:45:26Z","timestamp":1773647126000},"score":1,"resource":{"primary":{"URL":"https:\/\/pn.bmj.com\/lookup\/doi\/10.1136\/pn-2025-004804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,14]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,3,13]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/pn-2025-004804"],"URL":"https:\/\/doi.org\/10.1136\/pn-2025-004804","relation":{},"ISSN":["1474-7758","1474-7766"],"issn-type":[{"value":"1474-7758","type":"print"},{"value":"1474-7766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,14]]}}}